Drug Development

Jul 10, 2017
By Pharmaceutical Technology Editors
The National Institutes of Health says a new study showed that hydroxychloroquine reduced the transmission of Zika in pregnant mice.
Jul 05, 2017
By Pharmaceutical Technology Editors
ADV7103 is being evaluated in a Phase III trial in Europe in children and adults with distal renal tubulopathy acidosis. Results from the study are expected in the coming months.
Jul 05, 2017
By Pharmaceutical Technology Editors
Partners will use an AI-enabled platform to discover new small molecules across different therapeutic areas.
Jul 05, 2017
By Pharmaceutical Technology Editors
SOBI003 is a chemically modified variant of a recombinant human sulfamidase product candidate, using Sobi’s proprietary glycan modification technology.
Jul 03, 2017
By Pharmaceutical Technology Editors
The collaboration will focus on the discovery, development, and commercialization of novel therapeutics targeting an undisclosed G protein-coupled receptor (GPCR) that plays an important role in inflammatory diseases.
Jul 02, 2017
Pharmaceutical Technology
Pharma’s test of continuous manufacturing is starting with oral solid-dosage forms.
Jul 02, 2017
Pharmaceutical Technology
The more pharma science and technology change, the more business and policy concerns stay the same.
Jul 02, 2017
Pharmaceutical Technology
Industrial-scale continuous API manufacturing may offer cost and safety benefits.
Jul 02, 2017
Pharmaceutical Technology
By Pharmaceutical Technology Editors
Anil Kane, executive director, Global Head of Technical & Scientific Affairs at Patheon, shared his perspective of changes to solid-dosage pharmaceutical manufacturing.
Jun 29, 2017
By Pharmaceutical Technology Editors
The agency announced a plan to eliminate its existing orphan designation request backlog.
native1_300x100
lorem ipsum